Harvest Healthcare Ltd

harvesthealthcare.co.uk

Harvest Healthcare Ltd is the leading manufacturer and distributor of quality healthcare equipment to the NHS, Care Home and Community markets, throughout the UK and internationally. We are continually developing our range of products to deliver a complete solution for all modern care environments. Focused on meeting the ever-evolving needs of patients, Harvest deliver quality and value for money.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact, Medical

ENVEDA BIOSCIENCES CLOSES $68-MILLION COMBINED SERIES B EQUITY AND DEBT FINANCING

biotechnology news | December 22, 2022

news image

Enveda Biosciences announced that it has closed a $68-million equity and debt financing. Dimension led the Series B round, which included participation by multiple new institutional investors, including FPV, Jazz Venture Partners, Level Ventures, Amino Collective, Allen & Co, and Possible Ventures. All of Enveda’s current major investors, including True Ventures, Lux Capital, Wireframe Ventures, Hummingbird Ventures, and Two Sigma Ventures, also participated in the round. ...

Read More

Industrial Impact

BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY

Bio-Techne | October 13, 2022

news image

Bio-Techne Corporation announced the introduction of 3 novel TSA Vivid Fluorophores for highly sensitive fluorescent detection of RNAs and proteins in cells and tissues. Optimized for use with proprietary RNAscope ISH technology, the TSA Vivid Fluorophores enable researchers to illuminate RNA biomarkers with industry leading sensitivity and clarity, accelerating cellular phenotyping and functional analysis at single-cell and subcellular resolution. Ideal for use with FFPE and fres...

Read More

CIPLA AND STEMPEUTICS JOIN FORCES FOR THE LAUNCH OF STEMPEUCEL® IN INDIA

Cipla | August 24, 2020

news image

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due to Buerger's Disease and Atherosclerotic Peripheral Arterial Disease. It is the first allogeneic cell therapy product to be approved for commercial use in India and the first ste...

Read More

Medical

ABSCI OPENS DOOR TO NEW BIOTECHNOLOGY CAMPUS

Absci | October 23, 2021

news image

Absci Corporation the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the opening of its new campus located in Vancouver, Washington, a few miles east of the downtown location that housed the company for the last four years. “Absci has been an incredibly positive force in the Vancouver community since establishing its headquarters here in 2016 I have fol...

Read More
news image

Industrial Impact, Medical

ENVEDA BIOSCIENCES CLOSES $68-MILLION COMBINED SERIES B EQUITY AND DEBT FINANCING

biotechnology news | December 22, 2022

Enveda Biosciences announced that it has closed a $68-million equity and debt financing. Dimension led the Series B round, which included participation by multiple new institutional investors, including FPV, Jazz Venture Partners, Level Ventures, Amino Collective, Allen & Co, and Possible Ventures. All of Enveda’s current major investors, including True Ventures, Lux Capital, Wireframe Ventures, Hummingbird Ventures, and Two Sigma Ventures, also participated in the round. ...

Read More
news image

Industrial Impact

BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY

Bio-Techne | October 13, 2022

Bio-Techne Corporation announced the introduction of 3 novel TSA Vivid Fluorophores for highly sensitive fluorescent detection of RNAs and proteins in cells and tissues. Optimized for use with proprietary RNAscope ISH technology, the TSA Vivid Fluorophores enable researchers to illuminate RNA biomarkers with industry leading sensitivity and clarity, accelerating cellular phenotyping and functional analysis at single-cell and subcellular resolution. Ideal for use with FFPE and fres...

Read More
news image

CIPLA AND STEMPEUTICS JOIN FORCES FOR THE LAUNCH OF STEMPEUCEL® IN INDIA

Cipla | August 24, 2020

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due to Buerger's Disease and Atherosclerotic Peripheral Arterial Disease. It is the first allogeneic cell therapy product to be approved for commercial use in India and the first ste...

Read More
news image

Medical

ABSCI OPENS DOOR TO NEW BIOTECHNOLOGY CAMPUS

Absci | October 23, 2021

Absci Corporation the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the opening of its new campus located in Vancouver, Washington, a few miles east of the downtown location that housed the company for the last four years. “Absci has been an incredibly positive force in the Vancouver community since establishing its headquarters here in 2016 I have fol...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us